Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Objectives Hand osteoarthritis (OA) is a condition characterised by cartilage degradation and frequently erosive changes. Analgesics and non-steroidal anti-inflammatory drugs are used for symptomatic relief but are often poorly tolerated or contraindicated. Previous publications suggest hydroxychlor...

Full description

Bibliographic Details
Main Authors: Frank Buttgereit, Joachim Listing, Claudia Kedor, Jacqueline Detert, Rolf Rau, Siegfried Wassenberg, Tanja Braun, Pascal Klaus, Walter Hermann, Stefan Markus Weiner
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/7/2/e001660.full

Internet

https://rmdopen.bmj.com/content/7/2/e001660.full

Similar Items